Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Whitehawk Therapeutics (WHWK) Tax Provisions: 2020-2022

  • Whitehawk Therapeutics' Tax Provisions was N/A to -$9,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $2,000, marking a year-over-year change of. This contributed to the annual value of $2,000 for FY2021, which is negligibly% changed negligibly from last year.
  • As of Q4 2022, Whitehawk Therapeutics' Tax Provisions stood at -$9,000, which was down 200.00% from $9,000 recorded in Q2 2022.
  • Whitehawk Therapeutics' 5-year Tax Provisions high stood at $9,000 for Q2 2022, and its period low was -$9,000 during Q4 2022.
  • For the 2-year period, Whitehawk Therapeutics' Tax Provisions averaged around $500, with its median value being $1,000 (2020).